| scholarly article | Q13442814 |
| P50 | author | Kyle Steenland | Q22089123 |
| P2093 | author name string | Sarah S Knox | |
| Chuanfang Jin | |||
| Tony Fletcher | |||
| Cecil Pollard | |||
| Verónica M Vieira | |||
| Anoop Shankar | |||
| Alan M Ducatman | |||
| Stephanie J Frisbee | |||
| Kevin M Leyden | |||
| Susan Arnold | |||
| Joel A Halverson | |||
| A Paul Brooks | |||
| Arthur Maher | |||
| Patsy Flensborg | |||
| P2860 | cites work | The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water | Q24623988 |
| Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources | Q24626351 | ||
| Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
| Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
| Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 | Q24680576 | ||
| Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). | Q31109567 | ||
| Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals | Q34207902 | ||
| The toxicology of perfluorooctanoate | Q34343282 | ||
| Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
| Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
| Emerging endocrine disrupters: perfluoroalkylated substances | Q37100285 | ||
| Predictors of PFOA levels in a community surrounding a chemical plant. | Q37278944 | ||
| Perfluorooctanesulfonate and related fluorochemicals in albatrosses, elephant seals, penguins, and polar skuas from the Southern Ocean | Q38700834 | ||
| Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations | Q44379609 | ||
| Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk | Q45008329 | ||
| Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry | Q46439807 | ||
| Analysis of fluorotelomer alcohols, fluorotelomer acids, and short- and long-chain perfluorinated acids in water and biota | Q46761004 | ||
| Struggle for Quality in Determination of Perfluorinated Contaminants in Environmental and Human Samples | Q59206292 | ||
| Perfluorinated acids as novel chemical tracers of global circulation of ocean waters | Q81249137 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1873-82 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | The C8 health project: design, methods, and participants | |
| P478 | volume | 117 |
| Q37674896 | A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes |
| Q37059784 | A biomonitoring study on blood levels of beta-hexachlorocyclohexane among people living close to an industrial area |
| Q38209158 | A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans |
| Q28072372 | A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans |
| Q34478458 | Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community |
| Q34813325 | Acute Immunotoxic Effects of Perfluorononanoic Acid (PFNA) in C57BL/6 Mice |
| Q26155268 | An overview of the effects of organic compounds on women's reproductive health and birth outcomes |
| Q42159989 | Assessing the Spatial Distribution of Perfluorooctanoic Acid Exposure via Public Drinking Water Pipes Using Geographic Information Systems. |
| Q28393054 | Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population |
| Q33702676 | Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. |
| Q34273620 | Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation |
| Q33654524 | Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid. |
| Q28384784 | Biomonitoring in California firefighters: metals and perfluorinated chemicals |
| Q37559503 | Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids |
| Q28387100 | Causal inference considerations for endocrine disruptor research in children's health |
| Q34074733 | Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006. |
| Q64247225 | Cross-sectional study of the association between serum perfluorinated alkyl acid concentrations and dental caries among US adolescents (NHANES 1999-2012) |
| Q37072630 | Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers |
| Q77790988 | Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: evidence of racial/ethnic and geographic differences in PFAS exposure |
| Q52647308 | Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes. |
| Q34273663 | Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population |
| Q38836350 | Effect of high density lipoprotein cholesterol on the relationship of serum iron and hemoglobin with kidney function in diabetes |
| Q24633469 | Endocrine disrupting properties of perfluorooctanoic acid |
| Q36929670 | Endocrine disruptors and the breast: early life effects and later life disease |
| Q92050833 | Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines |
| Q24632957 | Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) |
| Q44550012 | Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model |
| Q51178718 | Exposure assessment of tetrafluoroethylene and ammonium perfluorooctanoate 1951-2002. |
| Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
| Q28383912 | Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant |
| Q33843051 | Geocoding rural addresses in a community contaminated by PFOA: a comparison of methods |
| Q36456177 | Impact of Exposure Uncertainty on the Association between Perfluorooctanoate and Preeclampsia in the C8 Health Project Population |
| Q40533182 | Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia |
| Q35504523 | Implications of early menopause in women exposed to perfluorocarbons. |
| Q36493907 | Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate |
| Q90751234 | Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response |
| Q30414928 | Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q43253111 | Maternal exposure to perfluorinated acids and fetal growth |
| Q40754376 | Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding |
| Q28383653 | Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts |
| Q37158816 | Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community |
| Q23915929 | Mortality and cancer incidence in ammonium perfluorooctanoate production workers |
| Q42837047 | PFOA and cancer in a highly exposed community: new findings from the C8 science panel |
| Q43351384 | PFOS and PFC releases and associated pollution from a PFC production plant in Minnesota (USA). |
| Q38711850 | Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community |
| Q47833635 | Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014. |
| Q28831121 | Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project |
| Q28393763 | Perfluoroalkyl chemicals and chronic kidney disease in US adults |
| Q39677606 | Perfluoroalkyl substances and beta cell deficient diabetes |
| Q59800731 | Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes |
| Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
| Q99592078 | Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults |
| Q64356907 | Perfluorohexanoic acid toxicity, part II: Application of human health toxicity value for risk characterization |
| Q33608031 | Perfluorooctanoate and neuropsychological outcomes in children |
| Q33984406 | Perfluorooctanoate exposure and major birth defects |
| Q36198328 | Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children |
| Q37374188 | Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant |
| Q34647222 | Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis |
| Q35874820 | Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community |
| Q42709872 | Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved? |
| Q35049761 | Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project |
| Q34689412 | Phlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series |
| Q38690520 | Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations |
| Q49644181 | Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial |
| Q37559515 | Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES). |
| Q35920263 | Polyfluoroalkyl compounds in Texas children from birth through 12 years of age. |
| Q38785639 | Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012. |
| Q33882623 | Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey |
| Q42680253 | Pregnancy-induced hypertension "probably linked" to PFOA contamination |
| Q36396103 | Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study |
| Q35127685 | Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry |
| Q34478572 | Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility |
| Q46251233 | Proposal for coordinated health research in PFAS-contaminated communities in the United States |
| Q28384774 | Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population |
| Q24633826 | Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia |
| Q36493895 | Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid |
| Q36229096 | Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley |
| Q35941864 | Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water |
| Q35682907 | Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q89754498 | Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program |
| Q28392052 | Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA |
| Q35591930 | Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. |
| Q36939320 | Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study |
| Q35941855 | Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. |
| Q41680536 | Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days |
| Q37241810 | Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. |
| Q36264053 | Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations |
| Q37902650 | Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project |
| Q40194249 | The Association of Perceived Memory Loss with Osteoarthritis and Related Joint Pain in a Large Appalachian Population |
| Q50156476 | The Exposure Experience: Ohio River Valley Residents Respond to Local Perfluorooctanoic Acid (PFOA) Contamination |
| Q35732800 | The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure |
| Q30241400 | Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). |
| Q36115374 | Thyroid function and perfluoroalkyl acids in children living near a chemical plant |
| Q37072627 | Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley |
| Q36601073 | Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population |
| Q64137858 | Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood |
| Q36433117 | Within- and between-group regression for improving the robustness of causal claims in cross-sectional analysis |
| Q48348398 | β-Cyclodextrin Attenuates Perfluorooctanoic Acid Toxicity in the Zebrafish Embryo Model. |
Search more.